Catalyst Wire Dossier Catalyst Wire Dossier

Sylvant

siltuximab
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for Sylvant, covering 2013-01-28 to 2026-07-30. Get the full timeline:

Most recent: EMA Authorised: Sylvant (siltuximab) — Recordati Netherlands B.V.

See pricing